10 results
6-K
LEGN
Legend Biotech Corp
6 Dec 21
Legend Biotech Corporation 6-K
8:30am
Corporation (the “Company”) announced the submission of a Regenerative Medical Product New Drug Application to Japan’s Pharmaceuticals and Medical … and statements relating to the timing and outcome of regulatory reviews relating to cilta-cel, including Legend Biotech’s submission of a Regenerative Medical
20-F
2020 FY
LEGN
Legend Biotech Corp
2 Apr 21
Annual report (foreign)
8:10am
of the commercial launch of the product.
In 2017, FDA established a new regenerative medicine advanced therapy, or RMAT, designation as part of its
424B4
zvmhh48v8gx 0h2
8 Jun 20
Prospectus supplement with pricing info
9:07am
F-1/A
cs79jz fkh
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
fcb9huuf
13 May 20
Registration statement (foreign)
4:41pm
DRS/A
6hsz9k8qz6f83nrzng
8 May 20
Draft registration statement (amended)
12:00am
DRS/A
dhelfzj9tbds khja8
20 Apr 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next